Abstract
Background Osteogenesis Imperfecta is a rare connective tissue disorder resulting in a diverse range of musculoskeletal deformities. Patient education is an important aspect of medical care, and the internet is a popular place in which patients seek information about their medical conditions. This is a cross-sectional study aimed to evaluate the quality of online patient educational websites about Osteogenesis Imperfecta.
Methods The authors searched for patient education websites using Google and Bing. Twenty patient education websites about Osteogenesis Imperfecta were collected from each. Websites meeting inclusion criteria were evaluated using the DISCERN tool, JAMA Benchmark Criteria evaluation, and a Flesch-Kincaid Readability test. T-tests were used to compare search engine results. Websites were also collected from ChatGPT3.5, however, due to hallucinations and exclusion criteria, the sample size was too small to compare to the search engines.
Results No significant differences were found between search engines, and the quality of the websites was not high. Average overall ratings for DISCERN were mediocre, and for the JAMA criteria they were low. The average readability scores required 8-9 grade level reading comprehension, although there was variability within each search engine.
Conclusion Neither search engine provided significantly better sources than the other, the overall quality of the websites was not high, and the low readability scores could make these difficult for patients with lower health literacy to understand
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval was not needed for this research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.